Status:

RECRUITING

Clinical Outcomes of Patients With Coronary Artery Disease

Lead Sponsor:

Shenyang Northern Hospital

Conditions:

Coronary Heart Disease (CHD)

Eligibility:

All Genders

18+ years

Brief Summary

Coronary heart disease (CHD) stands as a foremost contributor to global mortality, characterized by complex pathogenesis that renders conventional "one-size-fits-all" preventive strategies inefficient...

Detailed Description

Coronary heart disease (CHD) stands as a foremost contributor to global mortality. Despite the increasing investment in the prevention of risk factors and the popularization of percutaneous coronary i...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years old
  • Hospitalization due to either confirmed or suspected CHD combined with one of the following features: previous PCI or CABG; previous myocardial infarction; previous coronary angiography revealing ≥ 50% stenosis in major coronary vessels; presentation with chest pain and pre-test probability of CHD \> 65%; laboratory tests revealing objective evidence of myocardial ischemia; coronary CT angiography (CTA) showed ≥ 30% stenosis in major coronary vessels
  • Subjects undergoing at least one coronary imaging and one functional examination. Imaging examinations include coronary CTA, intravascular ultrasound (IVUS), or optical coherence tomography (OCT). Functional examination include fraction flow reservation (FFR), CT-FFR or quantitative flow ratio (QFR).
  • Written informed consent provided.

Exclusion

  • History of mental illness, drug or alcohol abuse, or being unable to cooperate with follow-up visits for any reason;
  • Life expectancy \<1 year
  • Pregnant or plan to be pregnant within 1 year
  • Subjects participating in any other clinical trial
  • Other conditions deemed unsuitable for inclusion by the investigator

Key Trial Info

Start Date :

February 21 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 31 2030

Estimated Enrollment :

10000 Patients enrolled

Trial Details

Trial ID

NCT06216847

Start Date

February 21 2024

End Date

October 31 2030

Last Update

September 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

General Hospital of Northern Theater Command

Shenyang, Liaoning, China, 110016